A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature
Abstract The human cytochrome P450 2D6 (CYP2D6) enzyme is part of phase-I metabolism and metabolizes at least 20% of all clinically relevant drugs. Therefore, it is an important target for drug-drug interaction (DDI) studies. High-throughput screening (HTS) assays are commonly used tools to examine...
Guardado en:
Autores principales: | Johannes Hochleitner, Muhammad Akram, Martina Ueberall, Rohan A. Davis, Birgit Waltenberger, Hermann Stuppner, Sonja Sturm, Florian Ueberall, Johanna M. Gostner, Daniela Schuster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/33a551dcc5004dd0b9cac26fa715e9a5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The cytochrome P450 (CYP) superfamily in cnidarians
por: Kirill V. Pankov, et al.
Publicado: (2021) -
An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase
por: Goutam Mukherjee, et al.
Publicado: (2021) -
Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cells
por: Tamara Heintze, et al.
Publicado: (2021) -
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase
por: Simon Bo Jensen, et al.
Publicado: (2021) -
Uncovering of cytochrome P450 anatomy by SecStrAnnotator
por: Adam Midlik, et al.
Publicado: (2021)